| 1 |
27454766 | The hydroxypyridinone iron chelator CP94 increases methyl-aminolevulinate-based photodynamic cell killing by increasing the generation of reactive oxygen species. | 2016 Oct |
3 |
| 2 |
24284114 | The effects of protoporphyrin IX-induced photodynamic therapy with and without iron chelation on human squamous carcinoma cells cultured under normoxic, hypoxic and hyperoxic conditions. | 2013 Dec |
4 |
| 3 |
20573043 | The hydroxypyridinone iron chelator CP94 can enhance PpIX-induced PDT of cultured human glioma cells. | 2010 Sep-Oct |
4 |
| 4 |
18239941 | Enhancement of methyl-aminolevulinate photodynamic therapy by iron chelation with CP94: an in vitro investigation and clinical dose-escalating safety study for the treatment of nodular basal cell carcinoma. | 2008 Aug |
3 |
| 5 |
17576385 | Direct comparison of delta-aminolevulinic acid and methyl-aminolevulinate-derived protoporphyrin IX accumulations potentiated by desferrioxamine or the novel hydroxypyridinone iron chelator CP94 in cultured human cells. | 2007 May-Jun |
2 |
| 6 |
10408393 | Comparative effect of ALA derivatives on protoporphyrin IX production in human and rat skin organ cultures. | 1999 Jul |
1 |
| 7 |
9440321 | A hydroxypyridinone (CP94) enhances protoporphyrin IX formation in 5-aminolaevulinic acid treated cells. | 1997 Nov |
1 |